|
Market Closed -
NYSE
16:00:02 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 1.770 USD | +1.72% |
|
+9.94% | -47.01% |
| 09-09 | TPG explores $5 billion sale of healthcare software company Lyric, sources say | RE |
| 08-10 | Clarivate Insider Bought Shares Worth $1,671,500, According to a Recent SEC Filing | MT |
Company Valuation: Clarivate Plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16,151 | 5,623 | 6,148 | 3,609 | 2,209 | 1,132 | - | - |
| Change | - | -65.18% | 9.33% | -41.3% | -38.78% | -48.75% | - | - |
| Enterprise Value (EV) | 21,207 | 10,280 | 10,498 | 7,832 | 6,201 | 1,132 | 1,132 | 1,132 |
| Change | - | -51.52% | 2.12% | -25.39% | -20.82% | -81.74% | 0% | 0% |
| P/E | -48x | -1.4x | -6.3x | -5.29x | -11.1x | -3.03x | -20.8x | -88.5x |
| PBR | 1.35x | 0.89x | 1.03x | 0.68x | 0.44x | - | - | - |
| PEG | - | -0x | 0.1x | 0.2x | 0.2x | -0x | 0.2x | 1.2x |
| Capitalization / Revenue | 8.61x | 2.11x | 2.34x | 1.41x | 0.9x | 0.51x | 0.56x | 0.55x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.51x | 0.56x | 0.55x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 1.2x | 1.26x | 1.22x |
| EV / EBIT | 0x | 0x | 0x | -0x | 0x | -10.3x | 8.02x | 7.26x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.49 | -5.97 | -1.47 | -0.96 | -0.3 | -0.585 | -0.085 | -0.02 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,877 | 2,661 | 2,629 | 2,557 | 2,455 | 2,209 | 2,017 | 2,068 |
| EBITDA 1 | 800.4 | 1,113 | 1,117 | 1,060 | 1,002 | 946.8 | 895.1 | 928 |
| EBIT 1 | 262.6 | 402.2 | 408.9 | -275.6 | 71.5 | -110 | 141.2 | 156 |
| Net income 1 | -312 | -4,036 | -986.6 | -668 | -201.1 | -374 | -52.6 | -9.95 |
| Net Debt | 5,056 | 4,657 | 4,350 | 4,224 | 3,992 | - | - | - |
| Reference price 2 | 23.520 | 8.340 | 9.260 | 5.080 | 3.340 | 1.770 | 1.770 | 1.770 |
| Nbr of stocks (in thousands) | 686,687 | 674,255 | 663,923 | 710,404 | 661,435 | 639,664 | - | - |
| Announcement Date | 3/10/22 | 3/1/23 | 2/27/24 | 2/19/25 | 2/24/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.03x | - | - | -.--% | 1.13B | |
| 26.61x | 9.48x | 17.94x | 0.91% | 127B | |
| 30.06x | 10.79x | 20.33x | 0.86% | 84B | |
| 27x | 6.11x | 15.29x | 2.36% | 47.21B | |
| 28.61x | 13.41x | 21.86x | 1.45% | 41.37B | |
| 20.86x | 4.22x | 11.67x | 2.03% | 33.18B | |
| 15.72x | 3.51x | 10.52x | 3.31% | 20.44B | |
| 19.04x | 2.84x | 11.7x | 2.47% | 19.77B | |
| 24.53x | 3.56x | 11.24x | 1.39% | 18.94B | |
| 21.29x | 5x | 12.49x | 3.12% | 16.88B | |
| Average | 21.07x | 6.55x | 14.78x | 1.79% | 40.96B | |
| Weighted average by Cap. | 25.79x | 8.25x | 16.80x | 1.52% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CLVT Stock
- Valuation Clarivate Plc
Select your edition
All financial news and data tailored to specific country editions
